H1 2026 saw stable sales and improved gross profit, but lower EBITDA and net result year-over-year. Perlen Packaging outperformed with higher organic growth, while Zeochem faced margin pressure. Outlook for 2026 is cautiously optimistic, with sales and EBITDA expected to rise slightly.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.